£59.83

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£60 today · all-time low £59 (Sep 2026) · usually £60

Springer Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days · 61 data points (no recent data)

Historical
Generating forecast…
£59.93 £58.56 £58.86 £59.16 £59.46 £59.76 £60.06 25 July 2026 09 August 2026 24 August 2026 08 September 2026 23 September 2026
View at Amazon ↗

Price data last checked 30 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 61 days • 2 price levels

Days at Price
Current Price
52 days 9 days · current 0 13 26 39 52 £59 £60 Days at Price

Price Analysis

Most common price: £59 (52 days, 85.2%)

Price range: £59 - £60

Price levels: 2 different prices over 61 days

Description

Individualized dosing regimens specific to the patient, infection, bacteria, and antibiotic can optimize outcome. Integration of pharmacokinetic and pharmacodynamic data, called dual individualization, can be accomplished through the use of AUIe. AUIC dosing has been shown to predict bacteriological outcomes, hasten clinical outcomes, reduce the emergence of resistance, and be cost-effective. MPC dosing has been shown to predict the emergence of resistant submutants. AUIC and MPC information can provide guidance as to when low doses can be used, and when higher concentrations are required. This strategy can ensure efficacy, minimize toxicity, reduce the opportunity for resistance to occur, and save money. REFERENCES I. Paladino JA. Streamlining antibiotic therapy: clinical application of pharmacokinetic and pharmacodynamic principles. J Osteopath Med 1991; 5: 16-25. 2. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance - a perspective: report of task force 6. Rev Infect Dis 1987; 9 (suppI3): S297-312. 3. Holmberg SO, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9: 1065-78. 4. Sanders cc. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clin Infect Dis 2001; 32(Suppl I ):S 1-8. 5. Ballow CH, Schentag 11. Trends in antibiotic utilization and bacterial resistance: report of the NNRSG. Diagn Microbiol Infect Dis. 1992; 15(suppl):37S-42S. 6. Rice LB, Eckstein EC, DeVente J, Shlaes OM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118-24.

Key Features

Used Book in Good Condition

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 December 2002
Listed Since
15 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)
97% match

Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)

Elsevier

£74.55 30 Sep 2026
Antibiotics: Methods and Protocols: 1520 (Methods in Molecular Biology, 1520)
97% match

Antibiotics: Methods and Protocols: 1520 (Methods in Molecular Biology, 1520)

Humana

£91.31 01 Oct 2026
Combination Therapy Against Multidrug Resistance
97% match

Combination Therapy Against Multidrug Resistance

Elsevier

£106.28 25 Sep 2026
21st Century Challenges in Antimicrobial Therapy and Stewardship (Frontiers in Anti-Infective Agents)
97% match

21st Century Challenges in Antimicrobial Therapy and Stewardship (Frontiers in Anti-Infective Agents)

£106.80 30 Sep 2026
Antimicrobial Resistance in the Environment
96% match

Antimicrobial Resistance in the Environment

Wiley

£106.12 19 Sep 2026
The Ongoing Challenge of Antimicrobial Resistance, An Issue of Infectious Disease Clinics of North America: Volume 34-4 (The Clinics: Internal Medicine, Volume 34-4)
96% match

The Ongoing Challenge of Antimicrobial Resistance, An Issue of Infectious Disease Clinics of North America: Volume 34-4 (The Clinics: Internal Medicine, Volume 34-4)

Elsevier

£68.02 22 Sep 2026
The Chemistry and Biology of Beta-Lactams
96% match

The Chemistry and Biology of Beta-Lactams

CRC Press

£105.00 27 Sep 2026
Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)
96% match

Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)

Springer

£76.42 23 Sep 2026
Antibiotics and Antibiotic Resistance in the Environment
96% match

Antibiotics and Antibiotic Resistance in the Environment

CRC Press

£100.01 27 Sep 2026
Antibiotic Resistance: 211 (Handbook of Experimental Pharmacology, 211)
96% match

Antibiotic Resistance: 211 (Handbook of Experimental Pharmacology, 211)

Springer

£110.00 19 Sep 2026
Antibiotic Resistance: 211 (Handbook of Experimental Pharmacology, 211)
96% match

Antibiotic Resistance: 211 (Handbook of Experimental Pharmacology, 211)

Springer

£277.72 18 Sep 2026
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
96% match

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

Springer

£119.08 02 Oct 2026
Antimicrobials: New and Old Molecules - Multi-resistant Bacteria
96% match

Antimicrobials: New and Old Molecules - Multi-resistant Bacteria

Springer

£108.75 02 Oct 2026
Antimicrobial Resistance and Implications for the 21st Century (Emerging Infectious Diseases of the 21st Century)
96% match

Antimicrobial Resistance and Implications for the 21st Century (Emerging Infectious Diseases of the 21st Century)

Springer

£97.00 24 Sep 2026